Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
04/2010
04/28/2010EP2179996A1 Sulfonated diarylrhodamine dyes
04/28/2010EP2178843A2 New ligands of the benzo[h]quinoline class and transition metal complexes containing them and use of said complexes as catalyst
04/28/2010EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof
04/27/2010US7705033 Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
04/22/2010WO2010045258A2 Spirocyclic gpr40 modulators
04/22/2010WO2010044981A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2
04/22/2010US20100099874 Transannular rearrangement of activated lactams
04/22/2010US20100099699 Peripheral opioid receptor antagonists and uses thereof
04/22/2010US20100098634 Imaging Agents Useful for Identifying AD Pathology
04/22/2010CA2739888A1 Spirocyclic gpr40 modulators
04/22/2010CA2736409A1 Benzoquinoline inhibitors of vesicular monoamine transporter 2
04/20/2010US7700617 Salt of naphthyridine carboxylic acid derivative
04/20/2010US7700616 Compounds and amyloid probes thereof for therapeutic and imaging uses
04/20/2010US7700593 Imidazo- and triazolo-pyridine compounds and methods of use thereof
04/20/2010CA2404311C Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/15/2010US20100094012 Heterodiamondoids
04/15/2010US20100094011 Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1h-3-indazolecarboxylic acid amides
04/14/2010EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof
04/14/2010CN101693689A New method for extracting and separating high-purity huperzine A from thousand-layer column
04/14/2010CN101693688A Indeno isoquinolone derivatives, preparation process and medical application thereof
04/13/2010US7696350 exo-7-(8-H-8-aza-bicyclo[3.2.1]oct-3-yloxy)-chromen-2-one; mood disorder, depression, dysthymic disorder, bipolar disorder, cyclothymic disorder; sleep disorders; psychological disorders
04/13/2010US7696239 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
04/13/2010US7696217 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
04/13/2010US7696188 7,8 and 9-substituted tetracycline compounds
04/13/2010US7696186 7,9-substituted tetracycline compounds
04/13/2010CA2425440C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/13/2010CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/08/2010US20100087426 Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
04/07/2010EP2172457A2 Fredericamycin derivatives
04/06/2010US7691878 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
04/06/2010US7691491 high durability, prepared at low cost; optical output with an extremely high efficiency and a high luminance; good luminescence hue of extremely high purity
04/01/2010US20100081819 Processes for the synthesis of tertiary amines
04/01/2010US20100081817 Processes for the selective amination of ketomorphinans
04/01/2010US20100081815 Recycling process for increasing the yield of opiate alkaloid derivatives
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081680 N-sulfonamido polycyclic pyrazolyl compounds
04/01/2010US20100081651 R(-)-11-hydroxyaporphine derivatives and uses thereof
03/2010
03/31/2010EP2167471A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
03/31/2010CN101684095A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/31/2010CN101684094A 3-substituted-1, 8-naphthalimide compound and synthesis method and medical application thereof
03/30/2010US7687514 Benzimidazole derivatives
03/30/2010CA2676881A1 Peripheral opioid receptor antagonists and uses thereof
03/30/2010CA2364705C Optically pure camptothecin analogues
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075112 Anthrapyridone compound or salt thereof, magenta ink composition and colored product
03/25/2010US20100075047 Anthrapyridone dyes and their preparation and use
03/25/2010US20100072438 Heptarylene-and octarylenetetracarboximides and preparation thereof
03/23/2010CA2465686C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine)
03/18/2010WO2010028542A1 Pleuromutilin phosphate, its pharmaceutical composition, preparation method and uses thereof
03/18/2010US20100069639 Processes for the Synthesis of Five and Six Membered Heterocyclic Rings
03/18/2010US20100069425 Glucocorticoid receptor modulator and methods of use
03/18/2010US20100069420 Spiro-piperidine inhibitors
03/18/2010US20100068786 Methods and compositions for reversing p-glycoprotein medicated drug resistance
03/18/2010US20100065828 compounds and organic light emitting diode using the same
03/18/2010US20100065827 Compounds and organic light emitting diode using the same
03/18/2010US20100065122 Organic Compound, Photovoltaic Layer and Organic Photovoltaic Device
03/18/2010DE102008046987A1 Phenylmalonsäurederivate Phenylmalonsäurederivate
03/16/2010US7679082 copolymers comprising rare earth metal complexes; light-emitting devices; improved semi-conductive properties and/or mechanical flexibility
03/16/2010US7678908 Process of preparing desaloratadine
03/16/2010US7678907 Halogenation of rylen-carboximides with elementary halogen in a two-phase mixture comprising an organic solvent and water, wherein formed halogen hydroxide is continuously removable from the organic solvent
03/16/2010US7678807 Isoquinoline and benzo[H] isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine H3 receptor
03/16/2010CA2437718C Carboline derivatives
03/11/2010WO2010026989A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide
03/11/2010WO2010026771A1 Nitrogenated heterocyclic compound and salt thereof, and bactericidal agent for agricultural or horticultural applications
03/11/2010US20100063288 Preparation of pigment red 149
03/11/2010US20100063055 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
03/09/2010US7674905 Fluoroquinolonoquinolones and inkjet ink compositions comprising the same
03/09/2010US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
03/04/2010US20100056789 Substituted Berbines and Processes for their Synthesis
03/04/2010US20100056562 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/02/2010US7671202 Perylene n-type semiconductors and related devices
03/02/2010US7671198 Process for preparing intermediates to 5-HT4 receptor agonist compounds
03/02/2010US7671068 N-(alkoxyalkyl) carbamoyl-substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE ¾ inhibitors
02/2010
02/25/2010WO2010021149A1 Spiro compound capable of inhibiting acid secretion
02/25/2010WO2008139452A3 Selective bromination of perylene diimides and derivatives thereof under mild conditions
02/25/2010US20100048906 Preparation of Substituted Morphinan-6-Ones and Salts and Intermediates Thereof
02/25/2010US20100048904 Dibenzorylenetetracarboximides as infrared absorbers
02/25/2010US20100048545 Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
02/23/2010US7667071 via by Hofmann rearrangement; intermediate to synthesize gabapentin, an antiepileptic agent; readily available starting materials with simple preparation, lower production cost, and higher product purity; pharmaceutical synthesis
02/23/2010CA2232288C Treating niddm with rxr agonists
02/18/2010WO2010018842A1 Benzofluoranthene derivative and organic electroluminescence element comprising same
02/18/2010US20100041693 Indolylmaleimide derivatives
02/18/2010US20100041690 Co-Administration of Dopamine-Receptor Binding Compounds
02/18/2010US20100040545 Radiolabelling methods
02/17/2010CN101648913A Blue light naphthalimide fluorescent compound
02/17/2010CN100590119C Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof
02/16/2010US7662862 Central nervous system disorders; compounds are 3-sulfonamidoalkyl 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylenes
02/16/2010US7662818 e.g. 4-[5-(piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; and multiple sclerosis
02/16/2010CA2406095C Synthetic process for the manufacture of an ecteinaschidin compound
02/16/2010CA2346082C Tricyclic .delta.3-piperidines as pharmaceuticals
02/16/2010CA2308551C Phenanthroline derivatives
02/11/2010WO2009138386A3 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
02/11/2010US20100035914 Azabicyclic compounds as inhibitors of monoamines reuptake
02/11/2010US20100035913 Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiestrase (PDE) 4 inhibitors
02/11/2010US20100035826 Controlled release of phenolic opioids
02/09/2010US7659282 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
02/09/2010US7659281 HMG-CoA reductase inhibitors
02/09/2010CA2406384C Synthesis of intermediates useful in preparing antihistamine tricyclic compounds
02/09/2010CA2274201C Di-or triaza-spiro[4,5]decane derivatives
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 110